NEW YORK (AFP) — The biotech sector is at the top of Wall Street’s worry list as analysts debate whether high-flying pharma stocks are a bubble that is about to burst.

Trade in biotech stocks was mixed Thursday as U.S. stocks clawed back near even after early losses. Biotech was a key factor in the market’s rout Wednesday, which included a 2.4 percent drop on the Nasdaq.